IL-6 signaling plays a crucial role in inflammation and cancer development, and several monoclonal antibodies targeting IL-6 or IL-6R have been developed as therapeutic agents for inflammatory diseases and cancers [24]. The gene discussed is IL6; the disease is cancer.